The CUHK research group led by Professor Tony Mok Shu-kam has decoded the common mutated genes in lung cancer and developed targeted therapies that have successfully increased patients’ lifespans. These innovative therapies redefined global paradigms in lung cancer treatment, providing patients with fresh hope. Professor Mok has established himself as one of the leading oncologists of the world, with his work on targeted EGFR inhibitors marking a significant milestone in the use of immunotherapy.
Scientific research has brought major changes to the world. CUHK brings together top researchers for the incubation of world-leading technologies into tangible applications and products under the university’s support. Advances in the fields of life and health technology, artificial intelligence, smart cities, robotics, and environment and sustainability have been in the spotlight in recent years. CUHK Innovation reveals the stories of CUHK scholars and alumni, and how they have applied innovative technologies in these fields to improve people’s health and life.
In the past two months, CUHK scholars gained international recognition from various disciplines for their outstanding research achievement. Three medicine scholars’ effective translation of non-invasive prenatal test and cancer diagnostic approaches from scientific research level into clinical application, has earned them inclusion in “Top 20 Translational Researchers of 2020” by the world-renowned scientific journal Nature Biotechnology.
Constant academic pursuit by scholars is essential to driving improvements in life and social progress. Scholars and research studies from CUHK have received international and national awards in various disciplines over the past few months, with research excellence widely recognised.
Science has the potential to change the world and the future of mankind. Through science, we can live a better life, or develop new vaccines, medicines, and technologies to prevent plagues, cure diseases, or explore the unknown possibilities. CUHK scholars reveal their research results on advancing human betterment. Their contributions to society have gained tremendous acclaim across global.
A new chapter is opening in cancer immunotherapy. A first-in-human clinical trial of CRISPR technology to treat late stage lung cancer has proved safe by a CUHK joint research. T-Cells of advanced condition patients have been extracted, gene edited and reinfused as potential fighters against cancer cells.